MICRONEEDLING ON CLINICAL PARAMETERS OF STRIAE ALBA AND MORPHOLOGICAL PARAMETERS OF THE FEMALE TEGUMENTARY SYSTEM

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 20, 2024

Primary Completion Date

July 20, 2024

Study Completion Date

September 1, 2024

Conditions
Striae; Atrophy
Interventions
DEVICE

Microneedling only

In this procedure, a derma roller composed of 1.5 mm microneedles from the Smart Derma Roller brand with 540 titanium needles was used. The protocol was performed by passing the derma roller ten times in the following directions: horizontal, vertical, and diagonal right and left.

OTHER

Microneedling and actives

In this procedure, a derma roller composed of 1.5 mm microneedles from the Smart Derma Roller brand with 540 titanium needles was used. The protocol was performed by passing the derma roller ten times in the following directions: horizontal, vertical, and diagonal right and left. Group G3 received microneedling associated with active ingredients. This manipulated active ingredient was composed of growth factors (EGF Factor, TGFß3 Factor, and IDP-2 Peptide), Hydroxyprolisilane, and hyaluronic acid.

Trial Locations (1)

93.022-750

Universidade do Vale do Rio dos Sinos, São Leopoldo

All Listed Sponsors
lead

Isabel de Almeida Paz

OTHER

NCT06636799 - MICRONEEDLING ON CLINICAL PARAMETERS OF STRIAE ALBA AND MORPHOLOGICAL PARAMETERS OF THE FEMALE TEGUMENTARY SYSTEM | Biotech Hunter | Biotech Hunter